Discovery of new lung cell may revolutionize cystic fibrosis drug research

Scientists have discovered a new type of cell—one that could radically change how researchers see cystic fibrosis. As part of a cellular mapping project, scientists identified a rare cell type that could affect rehydration and pH balance, which are integral to those with cystic fibrosis.

“One of the things I'm amazed about is that we could have made so much progress in cystic fibrosis research without knowing this piece of information,” said Jayaraj Rajagopal, MD, a pulmonologist and developmental biologist at Massachusetts General Hospital, in an interview with Scientific American. “That actually creates a huge amount of optimism in me, because it means that we can create a huge amount of progress without knowing everything.”

The research—published online August 1 in Naturecould be an important breakthrough in developing drug therapies for the condition that affects 70,000 people worldwide. Rajagopal said this discovery could reframe how scientists view the disease.

Read more at Scientific American at the link below:

""
Nicholas Leider, Managing Editor

Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.

Around the web

The American College of Cardiology has sent a letter to HHS Secretary Robert F. Kennedy Jr. that outlines some of the organization’s central priorities and concerns. 

One product is being pulled from the market, and the other is receiving updated instructions for use.

If the Trump administration continues taking a laissez-faire stance toward AI—including AI used in healthcare—why not let the states go it alone on regulating the technology?